Document:

Exhibit
10.1

 

Option
Agreement

 

This
Option Agreement (the “Agreement”) dated as of March 31, 2021 (the “Effective Date”)

 

By
and Between

 

	 	1)	Life
    Science Biosensor Diagnostics Pty Ltd., an Australian proprietary limited company having an address at Level 9, 85 Castlereagh,
    Sydney NSW 2000 Australia (“LSBD”);
	 	 	 
	 	2)	GBS
    Inc., a Delaware corporation having an office at 708 Third Avenue, 6th Floor, New York, NY 10017 (“GBS”);
    and
	 	 	 
	 	3)	BiosensX
    (North America) Inc., a company having an address at 733 3rd Ave., 16th Floor, New York, NY 10017
    (“BSX”)

 

LSBD,
GBS and BSX may each be referred to herein as a “Party” and collectively as the “Parties.”

 

RECITALS

 

WHEREAS,
LSBD owns:

 

	 	i.	technology
    related to measuring, or otherwise determining, the following: (a) the amount or concentration of glucose; (b) the existence
    of biological markers of cancer; and (c) allergy/immunology and hormones, each in a bodily fluid (e.g., saliva, blood) (each
    an “Indicator” and collectively the “Indicators”);
	 	 	 
	 	ii.	products
    (including, meters, strips, and accessories), systems, methods, processes, applications, and implementation for or of measuring
    or otherwise determining the amount or concentration and existence of each Indicator in a bodily fluid (individually and collectively,
    the “Biosensor Technology”); and
	 	 	 
	 	iii.	Proprietary
    Rights in and to Biosensor Technology (individually and collectively, the “Biosensor Proprietary Rights,”
    collectively with the Biosensor Technology, the “Biosensor IP”)

 

WHEREAS,
LSBD entered into that Technology License Agreement (“BSX Agreement”) dated September 12, 2019 BSX pursuant
to which LSBD, in part, granted a limited license to BSX the right to use, manufacture, market, offer and sell products including
using the Biosensor Technology in accordance with the terms and conditions of the BSX Agreement; and;

 

WHEREAS,
LSBD now wishes to grant, and GBS wishes to receive an exclusive option to acquire an exclusive license to use, make, have made,
market, sell and offer to sell Products under the Intellectual Property Rights in the Glucose Field in the Territory.

 

    	 	1	 

    	 

    

 

	1.	Definitions.
    

 

	 	1.1.	“Affiliate”
    means any entity or other legal or juridical person that, directly or indirectly, controls, or is controlled by, or is under
    common control with, a Party; whereby “control” of a person or Party means direct or indirect ownership of fifty
    percent (50%) or more of the beneficial or record ownership of the outstanding shares or other ownership interests or the
    direct or indirect power to designate fifty percent (50%) or more of directors, managers, or individuals exercising authority
    in its governance; provided that, notwithstanding the foregoing, LSBD, BSX and GBS shall not be deemed to be Affiliate of
    each other under or in connection with this Agreement.
	 	 	 
	 	1.2.	“Biosensor
    IP” has the meaning set forth in the Recitals, above.
	 	 	 
	 	1.3.	“Biosensor
    Proprietary Rights” has the meaning set forth in the Recitals, above.
	 	 	 
	 	1.4.	“Biosensor
    Technology” has the meaning set forth in the Recitals, above.
	 	 	 
	 	1.5.	“BSX”
    has the meaning set forth in the Preamble, above.
	 	 	 
	 	1.6.	“BSX
    Agreement” has the meaning set forth in the Recitals, above.
	 	 	 
	 	1.7.	“BSX
    Field” means any medical use excluding the Glucose Field.
	 	 	 
	 	1.8.	“BSX
    License” has the meaning set forth in Section 2.2.3 of this Agreement.
	 	 	 
	 	1.9.	“Confidential
    Information” means any data, documentation material, and information that is owned by a Party or is disclosed, provided,
    or made available by a Party (such Party, the “Disclosing Party”) to, or directly or indirectly obtained
    from the Disclosing Party by, the other Party (the “Receiving Party”) under or in connection with this
    Agreement, other than any data, documentation, material, and information that is Non-Confidential Information.
	 	 	 
	 	1.10.	“Exercise
    Notice” has the meaning set forth in Section 2.1.2 of this Agreement.
	 	 	 
	 	1.11.	“GBS”
    has the meaning set forth in the Preamble above.
	 	 	 
	 	1.12.	“GBS
    License” has the meaning set forth in Section 2.2.2 of this Agreement.
	 	 	 
	 	1.13.	“Glucose
    Field” means the treatment or management of diabetes
	 	 	 
	 	1.14.	“Indemnitees”
    has the meaning set forth in Section 5.1 of this Agreement.
	 	 	 
	 	1.15.	“Indicator”
    or “Indicators” has the meaning set forth in the Recitals, above.
	 	 	 
	 	1.16.	“Intellectual
    Property Rights” means Patent Rights, Biosensor IP, Technology Rights, registered and unregistered designs, copyrights,
    database rights, trademarks and trade names, internet domain names, know-how and other rights of the same or similar effect
    as any of the foregoing anywhere in the Territory, in each case whether registered or not, including pending applications
    for registration of such rights, developed or acquired by LSBD.

 

    	 	2	 

    	 

    

 

	 	1.17.	“Non-Confidential
    Information” means solely such information that, and to the extent it: (i) was known publicly, or was known by the
    Receiving Party without obligation of confidentiality or non-disclosure, at the time such Property was provided, disclosed,
    or made available or accessible by the Disclosing Party to, or obtained from the Disclosing Party by, the Receiving Party;
    or (ii) becomes known publicly thereafter through no action or fault of the Receiving Party or any of its employees, or (iii)
    is developed, created, discovered, or authored by the Receiving Party independently from this Agreement and any performance
    hereunder and independently from, and without reference to, any Confidential Information or Technology of the Disclosing Party,
    or acquired from a third party other than under a confidentiality and non-disclosure obligation; provided, however, that any
    and all.
	 	 	 
	 	1.18.	“Option
    Break Fee” means the five-hundred thousand USD that LSBD may pay to GBS in order to terminate this Agreement.
	 	 	 
	 	1.19.	“Option
    Fee” means five million USD ($5,000,000.00) to be paid by GBS to LSBD for purposes of exercising the Option granted
    herein and
	 	 	 
	 	1.20.	“Option
    Term” means two (2) calendar years from the Effective Date.
	 	 	 
	 	1.21.	“Patent
    Rights” means LSBD’s rights in the information or discoveries described in invention disclosures, or claimed
    in any patents and/or patent applications (including, without limitation, the patents and patent applications set forth in
    Schedule 1 to this Agreement), whether domestic or foreign and all divisionals, continuations, continuations-in-part, reissues,
    reexaminations or extensions of the patents and/or patent applications and any letters patent, domestic or foreign that issue
    thereon.
	 	 	 
	 	1.22.	“Permitted
    Disclosee” has the meaning set forth in Section 3.3 of this Agreement.
	 	 	 
	 	1.23.	“Permitted
    Uses” has the meaning set forth in Section 3.2 of this Agreement.
	 	 	 
	 	1.24.	“Product”
    means any product or service comprising the Intellectual Property Rights. Product includes, without limitation, any products
    relating to the Biosensor Technology as outlined in Schedule 2.
	 	 	 
	 	1.25.	“Regulatory
    Approval” means any and all marketing or regulatory approvals necessary to market and sell a Product in a jurisdiction
    in the Territory.
	 	 	 
	 	1.26.	“Research
    & Development Agreement” means that agreement dated December 14, 2020 entered into by and between LSBD and GBS
    pursuant to which GBS agreed to issue 3,000,000 shares of GBS’s common stock to LSBD in consideration of $2,000,000.00
    (the “Research and Development Consideration”) USD to be paid by LSBD to GBS toward the research and development
    of applications other than glucose and COVID-19 applications.

 

    	 	3	 

    	 

    

 

	 	1.27.	“Royalty
    Year” means, for each jurisdiction in the Territory, the one year period commencing on the first day of the first
    fiscal quarter that starts after the receipt of all required Regulatory Approvals in such jurisdiction, and for the one year
    period commencing on each anniversary of such day.
	 	 	 
	 	1.28.	“Technology
    Rights” means LSBD’s rights in any technical information, know- how, processes, procedures, compositions,
    devices, methods, formulae, protocols, techniques, software, designs, drawings or data, which may not be claimed in Patent
    Rights but may be necessary for practicing the Patent Rights.
	 	 	 
	 	1.29.	“Territory”
    means North America including the United States, Mexico and Canada and their respective territories and regions.

 

	2.	Option.

 

	 	2.1.	Option.

 

	 	2.1.1.	LSBD
    hereby grants to GBS an exclusive option to acquire an exclusive license (with the right to sublicense) to use, make, have
    made, market, sell and offer to sell Products under the Intellectual Property Rights in the Glucose Field in the Territory.
	 	 	 
	 	2.1.2.	Unless
    earlier terminated in accordance with Article 6 below, GBS may exercise the Option at any time during the Option Term by providing
    written notice of its decision to exercise (“Exercise Notice”) and the issuance of the Option Fee no later
    than 30 days from such Exercise Notice.

 

	 	2.2.	Effect
    of Exercise of Option. Upon LSBD’s exercise of the option granted pursuant and subject to this Agreement:

 

	 	2.2.1.	LSBD
    and BSX will promptly, but no later than 7 days from the exercise of the Option granted herein, mutually terminate the BSX
    Agreement with respect to the Territory;
	 	 	 
	 	2.2.2.	LSBD
    and GBS will promptly, but no later than 14 days from the exercise of the Option, enter into a written license agreement (“GBS
    License”) pursuant to which LSBD shall grant GBS an exclusive license (with the right to sublicense) to develop,
    use, make, have made, market, sell and offer to sell Products under the Intellectual Property Rights in the Glucose Field
    in the Territory. Except as specifically set forth in this Agreement or otherwise mutually agreed to by LSBD and GBS, the
    terms of the GBS License shall include substantially the same terms as set forth in the BSX Agreement, provided, however,
    the GBS License shall include the following milestone payment:

 

    	 	4	 

    	 

    

 

	 	2.2.2.1.	a
    commercialization milestone payment to the LSBD for the equivalent of 5 years royalties based upon agreed maintainable sales
    due 90 days from the end of the first Royalty Year. This is in addition to any agreed royalties payable under the GBS License.

 

	 	2.2.3.	LSBD
    and BSX will promptly, but not later than 14 days from the exercise of the Option, enter into a written license agreement
    (“BSX License”) pursuant to which LSBD shall grant BSX an exclusive license (with the right to sublicense)
    to use, make, have made, market, sell and offer to sell Products under the Intellectual Property Rights in the BSX Field in
    the Territory. Except as specifically set forth in this Agreement or otherwise mutually agreed to by LSBD and BSX, the terms
    of the BSX License shall include substantially the same terms as set forth in the BSX Agreement.
	 	 	 
	 	2.2.4.	Notwithstanding
    any terms to the contrary as may be set forth herein, any license(s) granted between the Parties with respect to Products
    for the treatment of COVID-19 in any territory in the world shall remain unchanged and unaffected by this Agreement and any
    terms set forth herein.

 

	 	2.3.	Consideration:
    In consideration for the option granted herein, GBS has completed payment of $500,000 to LSBD

 

	3.	Confidentiality

 

	 	3.1.	Obligations.
    The Receiving Party shall (a) take the same precautions to protect the confidentiality of the Confidential Information as
    it takes for its own Confidential Information, but in no event less than reasonable precautions and (b) cause any and all
    Persons to which access to the Confidential Information is given by such Receiving Party to enter into non-disclosure and
    confidentially agreements with the same terms set forth herein with regard to such Confidential Information. In the event
    that applicable law requires disclosure of any Confidential Information, the disclosure of such Confidential Information shall
    be subject to the following provisions of this Section 3.1. If the Receiving Party or any employee, agent or contractor is
    requested under, or required by, law to disclose any Confidential Information of the Disclosing Party, the Receiving Party
    shall provide the Disclosing Party with prompt notice of such request or requirement and reasonably assist the Disclosing
    Party with seeking an appropriate protective order or other remedy as decided by the Disclosing Party. If such protective
    order or other remedy is not obtained, or to the extent that the Disclosing Party waives compliance with the terms of this
    Agreement, the Receiving Party or any Permitted Disclosee (as defined below) will disclose only such of the Confidential Information
    it is legally required to disclose and will use its best efforts to ensure that all Confidential Information so disclosed
    will be accorded confidential treatment.

 

    	 	5	 

    	 

    

 

	 	3.2.	Permitted
    Use. The Receiving Party may use, copy, reproduce, and utilize any Confidential Information that is provided or made accessible
    by the Disclosing Party to the Receiving Party as necessary for such Receiving Party to perform any obligations or other activities
    of the Receiving Party, and to exercise any rights that the Receiving Party is granted or has, in or under this Agreement
    (collectively, “Permitted Uses”). For purposes of clarity, if the Receiving Party is GBS or BSX, then use
    of Confidential Information for purposes of determining whether to exercise the option granted herein, shall be considered
    a Permitted Use.
	 	 	 
	 	3.3.	Permitted
    Disclosure. The Receiving Party may disclose or make available any Confidential Information of the Disclosing Party to
    any employee or contractor of such Receiving Party solely as necessary for any Permitted Use and if and while such employee
    or contractor is subject to confidentiality and non-disclosure obligations (whether pursuant to a written agreement or written
    policy) that are no less stringent than those in this Section 6 (such employee or contractor, a “Permitted Disclosee”).
	 	 	 
	 	3.4.	Prohibitions.
    Except solely to the extent expressly permitted under Section 3.2 and Section 3.3, the Receiving Party hereby agrees that
    it will not, directly or indirectly, use, copy, reproduce, utilize, disclose, provide or reveal to, or permit or give access
    to, any third party, or publish, disseminate, or distribute, any Confidential Information of the Disclosing Party, or any
    part thereof, in whatever form or format.
	 	 	 
	 	3.5.	This
    Agreement. This Agreement, and the terms hereof are considered Confidential Information of the Parties, provided that
    the Parties may disclose and use this Agreement: (i) in connection with receiving legal or financial advice from a contractor
    that is subject to a confidentiality obligation regarding this Agreement; (ii) any assertion or enforcement of any right or
    remedy under or related to this Agreement; or (iii) if and to the extent required by law upon compliance with Section 3.1.
	 	 	 
	 	3.6.	On
    Request. On the request of the Disclosing Party, the Receiving Party must: (i) cease all use of the Confidential Information
    of the other party; (ii) destroy or delete all records and copies of the Confidential Information in its possession; (iii)
    return to the other party all other Confidential Information of the other party in its possession (including all copies of
    the same); and (iv) provide to the other party a written certificate confirming compliance with the requirements of this Section
    3.6, provided that each party may retain one copy of the Confidential Information of the other party to the extent required
    by law or for use solely in the event of a dispute arising out of this agreement. In complying with this clause, the Receiving
    Party shall not be required to destroy any copies of the Confidential Information which are maintained in electronic form
    in back-up tapes, servers, or other sources as a result of the Receiving Party’s normal back-up procedures for electronic
    data, provided that provided that such copies are: (v) collected under the Receiving Party’s usual back-up processes;
    (vi) are not readily accessible by the Receiving Party; and (vii) no attempt is made to recover such Confidential Information
    from the back-up tapes, servers or other sources (except for legal or compliance purposes).

 

	4.	Representations
    & Warranties. 

 

	 	4.1.	Mutual
    Representations and Warranties. Each Party hereby represents and warrants that:

 

	 	4.1.1.	it
    has the authority to enter into this Agreement;

 

    	 	6	 

    	 

    

 

	 	4.1.2.	it
    is not a party to any agreement of any kind that will or may prevent such Party from entering into or performing its obligations
    under this Agreement;
	 	 	 
	 	4.1.3.	the
    execution, delivery and performance of this Agreement by such Party has been duly and properly authorized by all necessary
    corporate actions, and this Agreement constitutes the valid and binding obligation of such Party;
	 	 	 
	 	4.1.4.	it
    will engage in any activities under this Agreement in a professional, good and workmanlike manner in compliance with all applicable
    law;
	 	 	 
	 	4.1.5.	the
    parties will make good faith efforts to enter into the BSX License and GBS License and, except as specifically set forth in
    this Agreement or otherwise mutually agreed to by the Parties, the terms of the BSX License and GBS License shall include
    subdstantially the same terms as set forth in the BSX Agreement.

 

	 	4.2.	GBS’s
    & BSX’s Representations and Warranties. Each of GBS and BSX hereby represent and warrants that during the Option
    Term it will not, directly or indirectly, challenge or contest LSBD’s ownership or rights in or to, or the validity
    or enforceability of, any Patent Rights, or assist or support any third party making such claim, challenge, or contest, that
    it will perform all activities under this Agreement without disclosing, deliberately or inadvertently, any confidential information
    of a third party or misappropriating or violating any third party’s property or right. The

 

	 	4.3.	LSBD’s
    Representations and Warranties. LSBD hereby represents and warrants that:

 

	 	4.3.1.	it
    is the legal and beneficial owner of all Intellectual Property Rights and will continue to be the legal and beneficial owner
    of all Intellectual Property Rights free of any and all encumbrances through the Option Term;
	 	 	 
	 	4.3.2.	GBS’s
    exercise of the option granted herein will not violate any third party’s property or rights in respect to the Intellectual
    Property Rights;
	 	 	 
	 	4.3.3.	To
    LSBD’s knowledge, no Person is infringing, misappropriating or otherwise violating the Intellectual Property Rights
    and LSBD has not made or threatened in writing any claims that any Person has infringed, misappropriated or otherwise violated
    any Intellectual Property Rights;
	 	 	 
	 	4.3.4.	LSBD
    has obtained from its employees, agents, consultants, contractors and other applicable Persons all written assignments of
    all rights in the Intellectual Property Rights developed by such Persons within the scope of their employment or engagement,
    as applicable and that no such Person has retained any ownership rights with respect to such created Intellectual Property
    Rights, including any ownership or other rights, license, claim or interest whatsoever in or with respect t any Intellectual
    Property Rights.

 

    	 	7	 

    	 

    

 

	5.	Liabilities.

 

	 	5.1.	Indemnity.
    LSBD hereby agrees to defend, indemnify and hold harmless GBS, its Affiliates and their respective officers, directors, employees
    and agents (collectively, “Indemnitees”) from and against any and all claims, actions, suits, litigations,
    demand, allegations, arbitrations, proceedings, judgments, orders, damages, losses, liabilities, injuries, costs, expenses
    (including, without limitation, reasonable attorney’s fees and witness and other defense costs), settlement and other
    payment obligations of any Indemnitee arising from or in connection with any third-party claims (“Claims”) arising
    from or related to LSBD’s breach of this Agreement, including without limitation, breach of any representation and warranty.
	 	 	 
	 	5.2.	Indemnification
    Procedure. A Party seeking indemnification shall give the indemnifying party prompt notice of any Claim served upon it
    or which the indemnified party has or should have knowledge of, and of any events that might give rise to such Claim, and
    shall fully cooperate with the indemnifying party and its legal representatives in the investigation, defense and settlement
    of any matter that is the subject of indemnification, and shall provide the indemnifying party with a right to seek, and shall
    cooperate with the indemnifying party in seeking, Claims against any third party to recover from that third party damages
    or other remedies related to the matters for which the indemnification obligations are incurred. The Parties shall not unreasonably
    withhold their approval of the settlement of any Claim by this indemnification obligation, provided that: (i) no settlement
    or compromise may be effected without the prior written consent of the indemnified party unless (a) there is no finding or
    admission of law or any rights of the indemnified party and no effect on any other Claim that may be made against the indemnified
    party, (b) the sole relief provided in monetary damages that are paid in full by the indemnifying party, and (c) the compromise
    or settlement includes, as an unconditional term thereof, a full release from all liability from the claimant or plaintiff
    to the indemnified party and (ii) the indemnified party shall have no liability with respect to any compromise or settlement
    effected without its written consent.

 

	6.	Term
    and Termination

 

	 	6.1.	Termination
    by LSBD. LSBD may only terminate this Agreement upon written notice to GBS and BSX, and the following conditions have
    been met:

 

	 	6.1.1.	GBS
    has failed to issue the Option Fee within 30 days of LSBD’s receipt of the Exercise Notice; or
	 	 	 
	 	6.1.2.	LSBD
    has matched the contribution paid by GBS into BSX as of the date termination of this Agreement is sought, including but not
    limited to (i) money and resources provided by GBS to BSX for the purpose of funding research, development, asset acquisitions,
    overhead and other costs of BSX reasonable incurred in relation to BSX activities; (ii) share capital in BSX or its subsidiary(ies);
    (iii) loans to BSX or its subsidiary(ies); and (iv) amount paid pursuant to invoices issued by BSX or its subsidiaries to
    GBS for the purpose of funding research, development, asset acquisitions, overhead and other costs of BSX reasonable incurred
    in relation to BSX activities; or

 

    	 	8	 

    	 

    

 

	 	6.1.3.	LSBD
    has completed payment of the Research & Development Contribution under the Research & Development Agreement; and

 

	 	6.1.4.	LSBD
    has completed payment of the Option Break Fee.

 

	 	6.2.	Effect
    of Termination. If this Agreement is terminated by GBS or LSBD or expires without the exercise of the Option granted herein,
    the BSX structure with its share allotments to LSBD and GBS continues and the licenses to BSX from LSBD, including the BSX
    License, shall continue and remain unaffected.
	 	 	 
	 	6.3.	Expiration.
    This Agreement shall automatically terminate upon the expiration of the Option Term.

 

	7.	Miscellaneous.

 

	 	7.1.	Remedies;
    Injunctive Relief. The Parties recognize that, in the event of any breach or anticipated breach of any provisions in Sections
    2, 3, and/or 4, the non-breaching party’s right to damages may not be sufficient to avoid, prevent, or compensate such
    non-breaching party for any harm arising from such breach. Therefore, the Parties expressly agrees that the non-breaching
    party is entitled to seek injunctive relief or specific performance, without need or obligation to post any bond, to enforce
    any right, license, obligation, agreement, covenant, term and condition in or under Sections 2, 3, and/or 4, in addition to
    any other rights and remedies available to Licensor, including, without limitation, any damages, all as the non-breaching
    party may elect in its sole discretion.
	 	 	 
	 	7.2.	Relationship
    of the Parties. The Parties agree that they are independent contractors and will always represent themselves to any third
    parties only as an independent contractor. The Parties are not, and nothing in this Agreement shall be interpreted that the
    Parties are, partners, joint venturers, co-owners or otherwise participants in a joint or common undertaking. The employees
    or agents of one Party are not, and shall not be construed to be, employees or agents of the other Party, and such other Party
    shall not be liable for, have any obligations to, and may not be bound by such employees and agents of the first Party.
	 	 	 
	 	7.3.	Compliance
    with the Law. Each Party shall perform all activities and obligations under or in connection with this Agreement in accordance
    with all applicable law.
	 	 	 
	 	7.4.	Assignment.
    The Parties may not transfer this Agreement, or assign any right or delegate any responsibility or obligation under this Agreement,
    in whole or in part, without the prior written consent of the other Party. Any attempted transfer, assignment, or delegation
    in contravention of the foregoing shall be null and void.
	 	 	 
	 	7.5.	Notice.
    All notices, demands, or other communications to be given or delivered to a Party under or by reason of a provision of this
    Agreement shall be in writing and shall be deemed to have been given to such Party when: (i) delivered personally to such
    Party at, or sent to such Party by reputable express courier service (charges prepaid) to, such Party’s address set
    forth in the caption of this Agreement or another address notified hereunder in writing at least thirty (30) days before such
    notice, demand, or other communication by such Party to the other Party, addressed to the attention of (a) the CEO (or equivalent)
    if notice is to Licensee, or (b) addressed to the attention of CEO (or equivalent) if notice is to Licensor.

 

    	 	9	 

    	 

    

 

	 	7.6.	Counterpart.
    This Agreement may be executed in one or more counterparts (any one of which may be by facsimile or PDF), all of which shall
    constitute one and the same agreement.
	 	 	 
	 	7.7.	Severability.
    If any provision of this Agreement is held to be invalid or unenforceable, the meaning of said provision will be construed,
    to the extent feasible, so as to render the provision enforceable, and if no feasible interpretation shall save such provision,
    it will be severed from the remainder of this Agreement, as appropriate. The remainder of this Agreement shall remain in full
    force and effect unless the severed provision is essential and material to the rights or benefits received by either Party.
    In such event, the Parties will use their best efforts to negotiate, in good faith, a substitute, valid and enforceable provision
    or agreement, which most nearly effects the Parties’ intent in entering into this Agreement, as appropriate.
	 	 	 
	 	7.8.	Entire
    Agreement; Amendment; Waiver. This Agreement constitutes the entire understanding and agreement between the Parties hereto
    related to the subject matter hereof. Neither this Agreement nor any term or provision hereof may be waived, changed, discharged
    or terminated except by an instrument in writing signed by the person against whom the enforcement of any waiver, change,
    discharge or termination is sought. No modification, amendment, supplement to or waiver of any provision of this Agreement
    will be binding upon the Parties unless made in a writing identifying the relevant provisions and signed by each Party through
    its authorized representative. A failure of either Party to exercise any right provided for herein shall not be deemed to
    be a waiver of any right hereunder. Any transfer, assignment, or delegation if permitted under this Agreement shall not constitute
    any modification, amendment, variation, or extension under the immediately preceding sentence if this Agreement does not change
    as a result of such assignment (other than the identity and contact information of the assignor to the assignee).

 

***
Signature Page Follows ***

 

    	 	10	 

    	 

    

 

IN
WITNESS WHEREOF, each Party has executed this Agreement as of the Effective Date.

 

Signed
as Accepted.

 

	Life Science Biosensor Diagnostic Pty Ltd (A.C.N 613 279 771)
	 	 	 
	 	 	 
	George
    Syrmalis – Director	 	Dated:
    March 31, 2021
	 	 	 
	 	 	 
	Con
    Tsigounis – Director	 	Dated:
    March 31, 2021
	 	 	 
	BiosensX
    (North America Inc.)	 	 
	 	 	 
	 	 	Dated:
    March 31, 2021
	George
    Syrmalis – Director & President	 	 
	 	 	 
	GBS
    Inc.	 	 
	 	 	 
	 	 	Dated:
    March 31, 2021
	Harry
    Simeonidis – Director & CEO	 	 

 

    	 	11Exhibit 4.4

SPAR GROUP, INC.

 

NONQUALIFIED STOCK OPTION CONTRACT

 

 

This Nonqualified Stock Option Contract has been entered into and is effective as of the 31st day of August, 2020 (as the same may be supplemented, modified, amended, restated or replaced from time to time in the manner provided herein, this "Contract"), between the SPAR Group, Inc., a Delaware corporation ("SGRP" or the "Company"), currently having an address at 1910 Opdyke Court, Auburn Hills, MI 48326 and Fay DeVriese (the "Optionee"), with an address at 662 Kingstone Court, Oakland, MI 48363. The Optionee and the Company may be referred to individually as a "Party" and collectively as the "Parties".

 

W I T N E S S E T H:

 

1.    Option Grant, No Plan, and Certain Definitions. The Company, in accordance with the resolution made by the Board of Directors of the Company grants to the Optionee an inducement option to purchase an aggregate of two hundred thousand (200,000) shares of the Common Stock, $.01 par value per share, issued by SGRP ("Common Stock") at an exercise price of $.85 per share (this "Option"). This Option is not intended to constitute an incentive stock Option within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended (the "Code"). This Contract and the Option granted hereunder are not granted under, subject to or governed by any past, present or future SGRP stock compensation plan. Certain Mutual Definitions and Interpretations (and other provisions) applicable to this Contract are set forth in Exhibit A hereto (as the same may thereafter be supplemented, modified, amended, restated or replaced from time to time, the "Mutual Interpretations"). Capitalized terms used and not otherwise defined herein shall have the meanings respectively assigned to them in the Mutual Interpretations. The Mutual Interpretations and all other exhibits and schedules attached to or incorporated by reference into this Contract are part of and incorporated by reference into this Contract as if fully set forth herein.

 

2.    No Employment Agreement and Other Agreements not Affected. Nothing in this Contract or the Option shall confer any right on the Optionee to become or continue as an employee of any SGRP Company, shall confer any voting, dividend or other stockholder right on the Optionee under any share of Common Stock, or shall in any was limit or restrict in any way with any right of any SGRP Company to terminate the Optionee's employment at any time for any reason whatsoever. The Optionee and the Company may enter or may have entered into other separate agreements. This Contract does not replace, amend or affect any other written offer or employment, severance, separation, termination or other agreement of between the Optionee and the Company (each a "Separate Agreement") and no other agreement shall replace, amend or affect this Contract(unless specifically referencing this Agreement by name and date).

 

3.    Term. This Contract shall be effective as of the date written above when executed by the Optionee. The term of this Option shall be ten (10) years from the date hereof, and accordingly the right to purchase any remaining shares of Common Stock under this Option shall expire on August 31, 2031, except for any earlier termination that may be expressly applicable under this Contract. No Option shall be subject to early expiration or termination except as otherwise expressly provided in this Contract.

 

4.    Vesting. Except for any earlier vesting provided in this Contract, this Option shall, provided the Optionee is then an employee of the Company, become vested and exercisable as to twenty-five percent (25%) of the total number of shares of Common Stock subject hereto on August 31, 2021, and the balance of the Option shall thereafter vest and become exercisable in a series of three successive equal annual installments upon the Optionee's completion of each additional year of employment over the three year period following August 31, 2021, such that the balance of the Option will be fully vested on August 31, 2024.

 

5.    Early Vesting and Termination. Except to the extent more favorable treatment may otherwise be expressly accorded to the Optionee in this Contract or in any Separate Agreement:

 

	
			(a)

				
			End of Employment. If the Optionee is no longer employed by any SGRP Company for any reason (other than the Optionee's Retirement, death or Disability), the Optionee may exercise any Option granted to the Optionee as an employee, to the extent vested and exercisable on the date of such termination or at any time within three (3) months after the date of termination, but not thereafter and in no event after the date the Option would otherwise have expired; provided, however, that if such relationship is terminated for Cause (as defined in the Mutual Interpretations), this Option shall terminate and be forfeited immediately, and the Optionee shall have no further rights or interest with respect to this Option.

			

 

	
			(b)

				
			Retirement. If any Optionee Retires, the Option granted to the Optionee under this Contract will become fully vested automatically and immediately notwithstanding any vesting schedule in the Contract, and may be exercised by the Optionee, or by the Optionee's Legal Representative (if applicable), at any time within the remaining term of and in accordance with this Option.

			

 

	
			(c)

				
			Death. If the Optionee dies while the Optionee is an employee of any SGRP Company, or within three (3) months after any other termination of such employment (unless such other termination was for Cause), the Option granted to the Optionee under this Contract will become fully vested automatically and immediately notwithstanding any vesting schedule in the Contract, and may be exercised by the Optionee's Legal Representative at any time within the remaining term of and in accordance with this Option.

			

 

 

 

 

	
			(d)

				
			Disability. If the Optionee is no longer employed by any SGRP Company due to the Optionee's Disability, the Option granted to the Optionee under this Contract will become fully vested automatically and immediately notwithstanding any vesting schedule in the Contract, and may be exercised by the Optionee, or by the Optionee's Legal Representative (if applicable), at any time within the remaining term of and in accordance with this Option.

			

 

	
			(e)

				
			Leave of Absence. An individual on military leave, sick leave or other bona fide leave of absence shall continue to be considered an employee for purposes of this Contract during such leave if the period of the leave does not exceed ninety (90) days, or, if longer, so long as the individual's right to re-employment with or re-engagement by such SGRP Company, as the case may be is guaranteed either by statute or by contract or such SGRP Company has consented by policy or in writing to a longer absence. If the period of leave exceeds ninety (90) days and the individual's right to re-employment is not guaranteed by statute, contract, policy or consent, the employment relationship shall be deemed to have terminated on the 91st day of such leave.

			

 

6.    Adjustments upon Changes in Common Stock and Extraordinary Events. Notwithstanding any other provision of this Contract, in the event of any change in the outstanding Common Stock by reason of a stock dividend, recapitalization, spin-off, split-up, combination or exchange of shares or the like that results in a change in the number or kind of shares of Common Stock that were outstanding immediately prior to such event, the aggregate number and kind of shares subject to this Contract (including the remaining availability and the components thereof), the aggregate number and kind of shares subject to each outstanding option and the exercise price thereof, shall be appropriately adjusted by the SGRP Compensation Committee to preserve the inherent economic value of the Awards and the intent and purposes of this Contract, consistent with this Contract and the applicable provisions of the Code, ERISA, Securities Law, Exchange Rules, Accounting Standards and other Applicable Law, and this mandatory adjustment and the SGRP Compensation Committee's determination of the mechanics of its implementation shall be conclusive and binding on all Parties and take effect on the Company's written notice to the Optionee. Such adjustment may provide for the elimination of fractional shares that might otherwise be subject to the Award without payment therefor and for the rounding up to the next whole cent in the case of exercise prices. Notwithstanding the foregoing, no adjustment shall be made pursuant to this Section if such adjustment (i) would cause this Contract to fail to comply with Section 409A or 422 of the Code or with Rule 16b-3 (if applicable to such Award), or (ii) would be considered as the adoption of a plan requiring stockholder approval.

 

(b)   Except as provided below but subject to compliance with Section 409A of the Code (if applicable), unless the SGRP Compensation Committee shall, in their sole discretion, determine otherwise, upon (i) the dissolution, liquidation or sale of all or substantially all of the business, properties and assets of the Company, (ii) any reorganization, merger or consolidation in which the Company does not survive, (iii) any reorganization, merger, consolidation or exchange of securities in which the Company does survive and any of the Company's stockholders have the opportunity to receive cash, securities of another Company and/or other property in exchange for their capital stock of the Company, or (iv) any acquisition by any person or group (as defined in Section 13(d) of the Securities Exchange Act) of beneficial ownership of more than fifty percent (50%) of the Company's then outstanding shares of Common Stock (other than ownership by Robert G. Brown, William H. Bartels, their respective families, trusts under which either of them is a trustee or beneficiary, and corporations and other entities under their individual or collective control) (each of the events described in clauses (i), (ii), (iii) and (iv) are referred to herein individually as an "Extraordinary Event"), this Contract shall terminate, and in such event Optionee shall have the right to exercise, in whole or in part, any unexpired option or options within twenty (20) business days of the Company's giving of written notice to the Optionee of such Extraordinary Event.

 

7.    Periodic Exercises. The right to purchase shares of Common Stock under this Option may be exercised in part from time to time and shall be cumulative, so that if the full number of shares purchasable or purchased in a period shall not be purchased, the balance may be purchased at any time or from time to time thereafter, but not after the expiration of the Option. Notwithstanding the foregoing, in no event may a fraction of a share of Common Stock be purchased under this Option.

 

8.    Option Exercises.  Exercise: An option (or any portion thereof), to the extent then exercisable, shall be exercised by giving written notice (an "Exercise Notice") to the Company (A addressed to its office at 1910 Opdyke Court, Auburn Hills, MI 48326, attention Chief Financial Officer, (B) specifying the option being exercised and the number of shares of Common Stock as to which such option is being exercised, and (C) accompanied by payment in full of the aggregate exercise price therefor (1) in cash and/or by certified check, (2) with the prior authorization of the Company, with previously acquired shares of Common Stock having an aggregate Fair Market Value on the date of exercise, equal to the aggregate exercise price of all options being exercised, (3) with a concurrent sale of option shares to the extent permitted by the Company, (4) through a "net exercise" method to the extent permitted by the Company, or (5) some combination thereof; provided, however, that in no case may shares be tendered if such tender would require the Company to incur a charge against its earnings for financial accounting purposes. The Company shall not be required to issue any shares of Common Stock pursuant to the exercise of any option until all required payments with respect thereto, including payments for any required withholding amounts, have been made.

 

(b)    Funding through Partial Broker Sale [Cashless Exercise]: The Company may, in their sole discretion, permit payment of the exercise price of an option by delivery by the Optionee of a properly executed Exercise Notice, together with a copy of the Optionee's irrevocable instructions to a broker acceptable to the Administrators to sell all or a portion of the option shares and deliver promptly to the Company the amount of sale or loan proceeds sufficient to pay such exercise price. In connection therewith, the Company may enter into agreements for coordinated procedures with one or more brokerage firms.

 

 

 

 

(c)    Funding through Share Offset [Net Exercise]: Upon its receipt of a properly executed Exercise Notice, the Company, in its sole discretion and to the greatest extent permitted by Accounting Standards and Applicable Law, may allow the payment or offset of the applicable exercise price of those exercised Option shares and pay the applicable tax withholding on behalf of the employee, by reducing the number of shares of Common Stock to be issued upon exercise by the largest whole number of shares with a fair market value not in excess of the aggregate Exercise Price and tax withholding, and then issuing only the net number of Option shares remaining to the Optionee.

 

(d)    Tax Witholdings. The Company may withhold cash and/or, with the authorization of the Administrators, shares of Common Stock to be issued to the Optionee in the amount which the Company determines is necessary to satisfy its obligation to withhold taxes or other amounts incurred by reason of the grant or exercise of this Option or the disposition of the underlying shares of Common Stock. Alternatively, the Company may require the Optionee to pay the Company such amount in cash promptly upon demand.

 

(e)    When Stockholder Rights Begin. An Optionee shall not have the rights of a stockholder with respect to such shares of Common Stock to be received upon the exercise of an option until the date of issuance of a stock certificate to the Optionee for such shares or, in the case of uncertificated shares, until the date an entry is made on the books of the Company's transfer agent representing such shares; provided, however, that until such stock certificate is issued or until such book entry is made, any Optionee using previously acquired shares of Common Stock in payment of an option exercise price shall continue to have the rights of a stockholder with respect to such previously acquired shares.

 

9.    Optionee's Acknowledgments and Agreements. The Optionee acknowledges, represents and warrants to and agrees with the Company that:

 

	
			(a)

				
			No Registration Statement under the Securities Act of 1933, as amended (the "Securities Act"), covers or will cover this Contract, the Option, or any of the shares of Common Stock purchasable through the exercise of the Option; and neither the Company nor any of its Representatives has ever promised or agreed to in any way ever prepare or file such a Registration Statement;

			

 

	
			(b)

				
			The shares of Common Stock to be issued upon the exercise of this Option will be acquired by the Optionee for his own account, for investment only and not with a view to the resale or distribution thereof. In any event, the Optionee shall notify the Company of any proposed resale of the shares of Common Stock issued to him upon exercise of this Option;

			

 

	
			(c)

				
			Any subsequent resale or distribution of shares of Common Stock by the Optionee shall be made only pursuant to (x) Rule 144, (y) a Registration Statement under the Securities Act that is effective and current with respect to the sale of shares of Common Stock being sold or (z) a specific exemption from the registration requirements of the Securities Act, but in claiming such exemption, the Optionee shall, prior to any offer of sale or sale of such shares of Common Stock, provide the Company (unless waived by the Company) with a favorable written opinion of counsel, in form and substance satisfactory to the Company, as to the applicability of such exemption to the proposed sale or distribution.

			

 

	
			(d)

				
			Nothing herein shall be construed as requiring the Company to register this Contract, the Option or the shares subject to this Option under the Securities Act.

			

 

	
			(e)

				
			The Company may affix appropriate legends upon the certificates for shares of Common Stock issued upon exercise of this Option and may issue such "stop transfer" instructions to its transfer agent in respect of such shares as it determines, in its discretion, to be necessary or appropriate to (a) prevent a violation of, or to perfect an exemption from, the registration requirements of the Securities Act, or (b) or any other agreement between the Company and the Optionee with respect to such shares of Common Stock.

			

 

	
			(f)

				
			The Optionee will comply with all applicable laws relating to the grant and exercise of this Option and the disposition of the shares of Common Stock acquired upon exercise of the Option, including without limitation, federal and state securities and "blue sky" laws.

			

 

	
			(g)

				
			The Company shall be entitled to withhold from amounts to be paid to the Optionee hereunder any federal, state or local withholding or other taxes or charges which it is from time to time required to withhold.

			

 

	
			(h)

				
			The Company shall be entitled to rely on an opinion of the independent tax, benefits or securities counsel selected and paid by the Company (which may be regular counsel of the Company) if any question as to the need or availability of any such a Securities Law exemption or the amount or requirement of any such withholding shall arise.

			

 

	
			(i)

				
			The above acknowledgements, representations, warranties and agreements shall also be deemed to be made by the Optionee upon each exercise of this Option.

			

 

10.    Mutual Agreement to Arbitrate. Binding Arbitration: The Optionee and the Company (on behalf of itself and each other SGRP Company) mutually consent and agree to the resolution by binding arbitration of any and all claims (whether under common law, statute, regulation or otherwise), that the Optionee may have against the Company, any other SGRP Company, or any of their respective Representatives, and all successors and assigns of any of them, or that the Company or other applicable SGRP Company might have against the Optionee, directly or indirectly arising under or involving this Contract oy the Option, in each case except for any Arbitration Exclusion as expressly provided (and defined) below. Except only for those Arbitration Exclusions, binding arbitration shall replace going before any government agency or a court for a judge or jury trial, and neither the Optionee, nor the Company nor any other applicable SGRP Company is permitted to bring any claim or action before any such entity. The Optionee and the Company (on behalf of itself and each other applicable SGRP Company) each waive the right to have a court or jury trial on any arbitrable claim. For clarity, the Company and at least one other applicable SGRP Company may (and sometimes will) all be involved in the same services or issues, and Optionee therefore agrees that any disputes that Optionee has with the Company or other SGRP Company shall be subject to binding arbitration as set forth in this Contract. "Arbitration Exclusion" shall mean any action, suit or other proceeding: (A) seeking any temporary or other injunction or restraining order or similar equitable relief in any jurisdiction; (D) seeking any enforcement of any arbitration or court award or judgment in any jurisdiction; (E) respecting any appeal of any lower court or arbitration decision; or (F) any claim that as a matter of law is not arbitrable.

 

 

 

 

(a)    Arbitration Law, Rules, Venue and Discovery: The Federal Arbitration Act ("FAA") shall govern this section, or if for any reason the FAA does not apply, the arbitration law of the state in which the Optionee last rendered labor or services to the Company or other applicable SGRP Company. Arbitration will be conducted pursuant to the applicable rules of the Judicial Arbitration and Mediation Services, Inc. ("JAMS"); provided, however, that if JAMS does not have an office within 200 miles of the place where the Optionee last rendered labor or services to the Company or other applicable SGRP Company, then the arbitration will be conducted pursuant to the rules of the American Arbitration Association ("AAA"). The arbitration will take place at the JAMS (or AAA) office closest to the place where the Optionee last rendered labor or services to the Company or other applicable SGRP Company. Each party to the arbitration shall have the right to take depositions of 4 fact witnesses and any expert witness designated by another party. Each party to the arbitration also shall have the right to make requests for production of documents to any party and to subpoena documents from third parties to the extent allowed by law. Requests for additional depositions or discovery may be made to the arbitrator. The arbitrator may grant such additional discovery if the arbitrator finds that the party has demonstrated that it needs that discovery to adequately arbitrate the claim, taking into account the parties' mutual desire to have a speedy, less-formal, cost-effective dispute-resolution mechanism. The JAMS rules are available at www.jamsadr.com, and the AAA rules are available at www.adr.org.

 

(b)    No Class or Collective Action; Government Complaints: Notwithstanding any provision of the JAMS (or AAA) rules, arbitration shall occur on an individual basis only. The Optionee and the Company (on behalf of itself and each other SGRP Company) each waive the right to initiate, participate in, or recover through, any class or collective action available to it. Nothing in this Contract prevents the Optionee, the Company or other applicable SGRP Company from filing or recovering pursuant to a complaint, charge, or other communication with any federal, state or local governmental or law enforcement agency.

 

(c)    Arbitration Fees and Costs: The Company will be responsible for paying any filing fee and the fees and costs of the arbitrator; provided, however, that if the Optionee is the arbitration party initiating the claim, the Optionee will contribute an amount equal to the filing fee to initiate a claim in the court of general jurisdiction in the state in which the Optionee last rendered Services to the Company or other applicable SGRP Company. Each party to the arbitration shall pay in the first instance its own arbitration and litigation costs and attorneys' fees, if any. However, if any party prevails on a statutory claim that affords the prevailing party attorneys' fees and/or arbitration or litigation costs, or if there is a written Contract providing for attorneys' fees and/or litigation costs, the arbitrator shall rule upon a motion for attorneys' fees and/or litigation costs under the same standards a court would apply under the law applicable to the claim(s) at issue.

 

11.    Consent to New York Governing Law, Jurisdiction and Venue; Waiver of Personal Service, Etc. To the greatest extent permitted by applicable law, this Contract shall be governed by and construed in accordance with the applicable federal law of the United States of America, and to the extent not preempted by such federal law, by the applicable law of the State of New York, in each case other than those conflict of law rules that would defer to the substantive laws of another jurisdiction. Except for matters requiring arbitration under the preceding Section, the Optionee and Company each hereby consents and agrees that the Supreme Court of the State of New York for the County of Westchester and the United States District Court for the Southern District of New York each shall have personal jurisdiction and proper venue with respect to any claim or dispute between the Optionee and the Company or other SGRP Company; provided that the foregoing consent shall not deprive any Party or beneficiary of the right in its discretion to voluntarily commence or participate in any other forum having jurisdiction and venue or deprive any Party of the right to appeal the decision of any such court to a proper appellate court located elsewhere. In any claim or dispute with the Company or any other SGRP Company, the Optionee will not raise, and hereby absolutely, unconditionally, irrevocably, expressly and forever waives, any objection or defense to any such jurisdiction as an inconvenient forum. Each Party hereby absolutely, unconditionally, irrevocably, expressly and forever waives personal service of any summons, complaint or other process on such Party or any authorized agent for service of such Party in any claim or dispute between the Optionee, the Company or any other SGRP Company (irrespective of whether more Parties may be involved). Each Party hereby acknowledges and agrees that service of process may be made upon such Party by (i) certified, registered or express mail, (ii) FedEx or other courier, (iii) fax, (iv) hand delivery or (v) any manner of service available under the applicable law, in each case at his or her address set forth above or as such other address as may be designated by such Party in a written notice received by SGRP. Each Party acknowledges and agrees that a final judgment in any such action, suit or proceeding shall be conclusive and binding upon such Party and may be enforced against such Party or any of his or her assets or properties in any other appropriate jurisdiction selected by the Company or other SGRP Company (in its sole and absolute discretion) by an action, suit or proceeding in such other jurisdiction. To the extent that each Party may be entitled to immunity from suit in any jurisdiction, from the jurisdiction of any court or from any other legal process, such Party hereby absolutely, unconditionally, irrevocably, expressly and forever waives such immunity.

 

12.    Mutual Survival of Obligations and Agreements, Etc. Except as otherwise expressly provided in this Contract, each of the representations, agreements and obligations of the Parties contained in this Contract (including Sections 9 through 18 and the Mutual Interpretations): shall be absolute and unconditional; and shall survive the execution and delivery of this Contract; shall remain and continue in full force and effect in accordance with its terms without regard to (i) each exercise of the Option (in whole or in part), (ii) the end of the Optionee's employment with the Company or other applicable SGRP Company, or (iii) any dispute involving any aspect of his or her employment or this Contract.

 

 

 

 

13.    Mutual Successors and Assigns; Assignment; Intended Beneficiaries. This Contract and the Option are not assignable, pledgable or otherwise transferable by the Optionee other than by will or the laws of descent and distribution and may be exercised, during the lifetime of the Optionee, only by the Optionee or the Optionee's Legal Representatives, provided, however, this Section shall not apply to a gratuitous transfer to (i) the Optionee's spouse, children or grandchildren (the "Family Members") or (ii) a trust established by the Optionee for the benefit of the Optionee or the Optionee's Family Members; or (iii) a partnership in which such Immediate Family Members are the only partners; provided that in all cases the Board of Directors or its delegate consents to such transfer and the transferee agrees in writing on a form prescribed by the Company to be bound by all provisions of this Contract. Without in any limiting the preceding restrictions, whenever in this Contract reference is made to any person, such reference shall be deemed to include the successors, assigns, and legal Representatives of such person, and, without limiting the generality of the foregoing, all representations, warranties, covenants and other Contracts made by or on behalf of such Party in this Contract shall inure to the benefit of the successors and assigns of the other Party. The representations, Contracts and other provisions of this Contract (including injunctive relief and arbitration) are for the exclusive benefit of the Parties hereto and the other SGRP Companies, and, except as otherwise expressly provided herein, no other person shall have any right or claim against any Party by reason of any of those provisions or be entitled to enforce any of those provisions against any Party. The provisions of this Contract are expressly intended to benefit each SGRP Company, which may enforce any such provisions directly, irrespective of whether the Company participates in such enforcement. However, no SGRP Company other than the Company shall have, or shall be deemed, interpreted or construed to have, any obligation or liability to the Optionee under this Contract or otherwise.

 

14.    Interpretation, Headings, Severability, Reformation, Etc. The Parties agree that the provisions of this Contract have been negotiated, shall be construed fairly as to all Parties, and shall not be construed in favor of or against any Party. The section headings in this Contract are for reference purposes only and shall not affect the meaning or interpretation of this Contract. In the event that any provision of this Contract shall be determined to be superseded, invalid, illegal or otherwise unenforceable pursuant to applicable law by a court or other governmental authority having jurisdiction and venue because of the scope or duration of any such provision, the Parties agree that such court or other governmental authority shall have the power, and is hereby requested by the Parties, to reduce the scope or duration of such provision to the maximum permissible under applicable law so that said provision shall be enforceable in such reduced form. In the event that any provision of this Contract shall be finally determined to be superseded, invalid, illegal or otherwise unenforceable (in whole or in part) pursuant to applicable law by an court or other governmental authority having jurisdiction and venue, that determination shall not impair or otherwise affect the validity, legality or enforceability (a) by or before that court or other governmental authority of the remaining provision of this Contract, which shall be enforced as if the unenforceable provision were deleted or limited to the extent provided by such determination, in each case unless the deletion or limitation of the unenforceable provision would impair the practical realization of the principal rights and benefits of the SGRP Companies hereunder (if and to the extent so limited), or (b) by or before any other court or other governmental authority of any of the provisions of this Contract.

 

15.    Mutual Non-Waiver by Action, Cumulative Rights, Etc. Any waiver or consent from any Party or (as to its rights) any SGRP Company respecting any provision of this Contract shall be effective only in the specific instance for which given and shall not be deemed, regardless of frequency given, to be a further or continuing waiver or consent. The failure or delay of any Party at any time to require performance of, or to exercise or enforce its rights or remedies with respect to, any provision of this Contract shall not affect the right of any Party at a later time to exercise or enforce any such provision. No notice to or demand on any Party shall entitle such Party to any other or notice or demand in similar or other circumstances. All rights, remedies and other interests of each Party hereunder are cumulative and not alternatives, and they are in addition to (and shall not limit) any other right, remedy or other interest of any Party under this Contract or applicable law.

 

16.    Mutual Waiver of Jury Trial, All Waivers Intentional, Etc. In any action, suit or proceeding in any jurisdiction brought against the Optionee by the Company or any other SGRP Company, or vice versa, each Party and the Company each waive trial by jury. This waiver of jury trial by each Party, and each other waiver, release, relinquishment or similar surrender of rights (however expressed) expressly made by a Party in this Contract has been absolutely, unconditionally, irrevocably, knowingly and intentionally made by such Party.

 

17.    Mutual Counterparts; Amendments. This Contract or any supplement, modification or amendment to this Contract may have been executed in writing or approved electronically in counterpart copies of the document or of its signature page, each of which may have been delivered by mail, courier, telecopy or other electronic or physical means, but all of which, when taken together, shall constitute a single Contract binding upon all of its signing or approving parties. This Contract (i) may not be supplemented, modified, amended, restated, waived, extended, discharged, released or terminated orally, (ii) may only be supplemented, modified or amended in a document executed in writing and/or approved electronically by all of the Parties hereto specifically referencing this Contract by date, title, parties and provision(s) being amended, and (iii) may only be waived, released or terminated in a document executed in writing and/or approved electronically by each Party or other person against whom enforcement thereof may be sought.

 

18.    Entire Agreement. Each Party acknowledges and agrees that, in entering into this Contract, it has not directly or indirectly received or acted or relied upon any representation, warranty, promise, assurance or other agreement, understanding or information (whether written, electronic, oral, express, implied or otherwise) from or on behalf of the other Party, or (in the case of the Optionee) from any other SGRP Company, or any of their respective Representatives, respecting any of the matters contained in this Contract, except for those expressly set forth in this Contract. Except for any Separate Agreement: this Contract (including all exhibits and schedules) contains the entire Contract and understanding of the Parties and supersede and completely replace all prior and other representations, warranties, promises, assurances and other Contracts, understandings and information, whether written, electronic, oral, express, implied or otherwise, from a Party or between them, or (in the case of the Optionee) from any other SGRP Company, with respect to the Option and the related matters contained in this Contract.

 

 

 

 

In Witness Whereof, and in consideration of the provisions set forth in this Contract and other good and valuable consideration (the receipt and adequacy of which is hereby acknowledged by each of them), the Parties hereto have executed and delivered this Contract intending to be legally bound by it and for it to be effective as of the earliest of date first written above and the dates written below:

 

 

	
			EMPLOYER:

				 	
			OPTIONEE: 

			
	
			SPAR Group, Inc.

				 	
			Fay DeVriese

			[▲ Please Type or Print Full Name of Employee ▲]

			
	 	 	 
	
			By:                                                             

				 	                                                                                            
	
			[ ▲ Officer's Signature ▲]

			        Kori Belzer, COO

				 	
			[ ▲ Optionee's Signature ▲ ]

			
	
			Employer's Current Address:

				 	
			Employee's Current Address:

			
	
			1910 Opdyke Court, Auburn Hills, MI 48326

				 	
			662 Kingstone Court

			
	
			ATTN: Human Resources Department

				 	
			Oakland, MI 48363                                             

			
	
			Dated as of: August 31, 2020

				 	
			Dated as of: August 31, 2020

			

 

 

 

 

EXHIBIT B – MUTUAL DEFINITIONS AND INTERPRETATIONS

 

The definitions, interpretations and other provisions of this Exhibit B shall apply to, and are hereby incorporated by reference into, the Agreement and each applicable SOW, schedule and exhibit. Capitalized terms shall have the meanings assigned to them in this Exhibit, and terms not so defined shall have the meanings assigned to them elsewhere in this Agreement.

 

I.         Certain Defined Terms

 

"Affiliate" of a referenced person shall mean: (i) any direct or indirect subsidiary or parent of such person; (ii) any other person directly or indirectly controlling, controlled by or under common control with the referenced person, whether through ownership, by contract, arrangement or understanding or otherwise; (iii) any person (a "Significant Shareholder") that has more than ten percent of the equity of, profits from or voting power respecting a referenced person, whether beneficially or otherwise; (iv) any director, officer, partner, manager or other executive of a referenced person (an "Officer"); (v) any member of the immediate family of any Significant Shareholder or Officer of the referenced person, including any child, stepchild, parent, stepparent, spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, wherever residing (each a "Relative"); (vi) any other person in which a Significant Shareholder, Officer or Relative of the referenced person also is a Significant Shareholder or Officer of such other person; or (vii) any other person that is, or is deemed to be, an affiliate, family member or other related party of the referenced person under any Applicable Law. However, no Party shall (for the purposes of this Agreement) be treated as or deemed to be an Affiliate or Representative of the other Party." Accounting Standards" shall mean the generally accepted accounting standards then in effect, as established, supplemented, modified, amended, restated or replaced from time to time by the Financial Accounting Standards Board and other generally recognized U.S. accounting authorities.

 

"Applicable Law" shall mean, to the extent applicable: (i) any Exchange Rules; (ii) ERISA, the Code or other federal tax or similar law; (iii) the Securities Law and other federal law of the United States of America; (iv) the DEGCL and the DEUCC; (v) to the extent that such federal law is not dispositive and does not preempt local law, and the DEGCL and DEUCC are not applicable, the Applicable Law of the State of New York; and (vi) to the extent the foregoing are inapplicable, any other applicable federal, state, territorial, provincial, county, municipal or other governmental or quasi-governmental law, statute, ordinance, requirement or use or disposal classification or restriction; whether domestic or foreign; in each case (A) including (without limitation) any and all rules and regulations promulgated under any of the foregoing and then in effect, and (B) as the same may be adopted, supplemented, modified, amended or restated from time to time or any corresponding or succeeding law or provision.

 

"Business Day" shall mean any day other than (i) any Saturday or Sunday or (ii) any day the Securities and Exchange Commission is closed''''.

 

"Cause" shall mean, in connection with the termination of an Awardee, (I) "cause", as such term (or any similar term, such as "with cause", "Termination for Cause", or the like) is defined in any employment, consulting, severance, or other applicable agreement for services or termination agreement between such Awardee and any SGRP Company or SGRP Consultant, or (II) in the absence of such an agreement, "cause" as such term is defined in the Contract executed by the Corporation and such Awardee pursuant to Section 10, or (III) in the absence of both of the foregoing, any of the following reasons: (other than where the applicable events are based upon or also constitute good reason for the Awardee's actions) (i) the Awardee's willful, grossly negligent or repeated breach (whether through neglect, negligence or otherwise) in any material respect of, or the Awardee's willful, grossly negligent or repeated nonperformance, misperformance or dereliction (whether through neglect, negligence or otherwise) in any material respect of any of his or her duties and responsibilities to any SGRP Company or the Awardee's employer, whether under, any agreement or document with any SGRP Company or the Awardee's employer, any of the directives, ethics or other codes, controls, policies or procedures of any SGRP Company or the Awardee's employer adopted or implemented from time to time, or otherwise, in each case other than in connection with any excused absence or diminished capacity; (ii) the gross or repeated disparagement by the Awardee of the business or affairs of the Corporation, any SGRP Company, Awardee's employer or any of their Representatives that in the reasonable judgment of SGRP adversely affected or would be reasonably likely to adversely affect the operations or reputation of any such person; (iii) any resume, application, report or other information furnished to any SGRP Company or Awardee's employer by or on behalf of the Awardee shall be in any material respect untrue, incomplete or otherwise misleading when made or deemed made; (iv) the Awardee is indicted for, charged with, admits or confesses to, pleads guilty or no contest to, adversely settles respecting or is convicted of (A) any willful dishonesty or fraud (whether or not related to any SGRP Company or Awardee's employer) (B) any material breach of any Applicable Law, (C) any assault or other violent crime, (D) any theft, embezzlement or willful destruction by the Awardee of any asset or property of any SGRP Company or Awardee's employer or any of their respective representatives, customers or vendors, (E) any other misdemeanor involving moral turpitude, or (F) any other felony; (vi) alcohol or drug abuse by the Awardee; or (v) any other event or circumstance that constitutes cause for termination of an employee under Applicable Law and is not described in another clause of this subsection; provided, however, that termination for Cause shall not be considered present unless the same has been determined by the SGRP Compensation Committee in their sole and absolute discretion.

 

"Charter" shall mean, as and to the extent applicable, the By-Laws of the Corporation, as amended, the charter of the SGRP Compensation Committee or other applicable SGRP Committee, as amended, and all resolutions of the Board, SGRP Compensation Committee or such other committee having continuing effect.

 

"Code" shall mean the Internal Revenue Code of 1986, as amended, and any and all rules and regulations promulgated thereunder and then in effect.

 

"DEGCL" shall mean the General Corporation Law of the State of Delaware, as amended.

 

"DEUCC" shall mean Article 8 of the Uniform Commercial Code of the State of Delaware, as amended.

 

"Disability" shall mean a permanent and total disability within the meaning of Section 22(e)(3) of the Code.

 

"Exchange Rules" shall mean the charter or other organizational or governance document or listing or other requirements of the applicable national securities exchange or market on which SGRP's stock is listed or quoted (currently Nasdaq), or any other applicable self-regulatory or governing body or organization, and the rules and regulations promulgated thereunder, as the same may be adopted, supplemented, modified, amended or restated from time to time or any corresponding or succeeding rule, regulation or provision.

 

 

 

 

"ERISA" shall mean the Employee Retirement Income Security Act of 1974, as amended, and any and all rules and regulations promulgated thereunder and then in effect.

 

"Fair Market Value" shall mean the fair market value of a share of Common Stock on any day that shall be: (i) if the principal market for the Common Stock is a national securities exchange, the closing sales price per share of the Common Stock on such day as reported by such exchange or on a consolidated tape reflecting transactions on such exchange; or (ii) if the principal market for the Common Stock is not a national securities exchange, the average of the closing bid and asked prices per share for the Common Stock on such day as reported on the OTC Bulletin Board Service or by National Quotation Bureau, Incorporated or a comparable service; provided, however, that if clauses (i) and (ii) of this subsection are all inapplicable because the Corporation's Common Stock is not publicly traded, or if no trades have been made or no quotes are available for such day, the fair market value of a share of Common Stock shall be determined by the Administrators by any method consistent with the provisions of the Code, ERISA, Securities Law, Exchange Rules and Accounting Standards applicable to the relevant Awards.

 

"Legal Representative" shall mean the executor, administrator or other person who at the time is entitled by law to exercise the rights of a deceased or incapacitated Awardee with respect to an Award.

 

"Representative" shall mean any shareholder, partner, member, director, executive, manager, officer, employee, contractor or subcontractor (in each case excluding a Party in the case of the other Party and excluding both Parties in the case of a Third Party), attorney, agent or other representative of the referenced person or any of its subsidiaries or other Affiliates. The Company's Representatives include (without limitation) the field administrators and the independent field merchandisers, technicians and other specialists engaged by the Company or its Affiliates and utilized in the Services.

 

"Retires" and "Retirement" shall mean the voluntary termination by an Awardee of such person's status as a director (whether or not an employee), officer (whether or not an employee), employee or consultant to any SGRP Company or SGRP Consultant, in each case so long as: (i) such person shall be at least 65 years of age or such younger age as (A) may be specifically provided for retirement in the applicable Contract or Awardee's written employment, consulting, retirement or termination contract, or (B) the Administrators in their discretion may permit in any particular case or class of cases; and (ii) such person shall not be employed full time by anyone else except as (A) may be otherwise specifically permitted following retirement in the applicable Contract or Awardee's written employment or consulting or termination contract, or (B) the Administrators in their discretion may permit in any particular case or class of cases.

 

"Securities Act" shall mean the Securities Act of 1933, as amended, and any and all rules and regulations promulgated thereunder and then in effect.

 

"Securities Exchange Act" shall mean the Securities Act of 1934, as amended, and any and all rules and regulations promulgated thereunder and then in effect.

 

"Securities Law" shall mean the Securities Act, the Securities Exchange Act, the Sarbanes-Oxley Act of 2002, as amended, any "blue sky" or other applicable federal or state securities law, or any other comparable law of any applicable jurisdiction, as amended and any and all rules and regulations promulgated thereunder and then in effect,.

 

"SGRP Board" shall mean the Board of Directors of SGRP.

 

"SGRP By-Laws" shall mean the By-Laws of SGRP, including (without limitation) the charters of the SGRP Audit Committee, SGRP Compensation Committee and the SGRP Governance Committee, as the same may have been and hereafter may be adopted, supplemented, modified, amended or restated from time to time in the manner provided therein.

 

"SGRP Committee" shall mean the SGRP Board's Audit Committee, the SGRP Board's Compensation Committee, the SGRP Board's Governance Committee or any other committee of the SGRP Board established from time to time, as applicable.

 

"SGRP Compensation Committee" shall mean the SGRP Board's Compensation Committee.

 

"SGRP Company" shall mean SPAR Group, Inc., a Delaware corporation ("SGRP"), or any direct or indirect subsidiary of SGRP. The subsidiaries of SGRP at the referenced date are listed in Exhibit 21.1 to SGRP's most recent Annual Report on Form 10-K as filed with the U.S. Securities and Exchange Commission (a copy of which can be viewed at the Company's website (www.sparinc.com) under the tab/sub-tab of Investor Relations/SEC Filings).

 

II.         Singular and Plural Forms, Headings, No Third Party Beneficiaries, and other Interpretations. 

 

In this Agreement, the Parties expressly agree that: (a) the meaning of each capitalized term or other word or phrase defined in singular form also shall apply to the plural form of such term, word or phrase, and vice versa; each singular pronoun shall be deemed to include the plural variation thereof, and vice versa; and each gender specific pronoun shall be deemed to include the neuter, masculine and feminine, in each case as the context may permit or required; (b) any bold text, italics, underlining or other emphasis, any table of contents, or any caption, section or other heading is for reference purposes only and shall not affect the meaning or interpretation of this Agreement; (c) the word "event" shall include (without limitation) any event, occurrence, circumstance, condition or state of facts; (d) this Agreement includes each schedule and exhibit hereto and each SOW, all of which are hereby incorporated by reference into this Agreement, and the words "hereof", "herein" and "hereunder" and words of similar import shall refer to this Agreement (including all schedules and exhibits hereto) and the applicable statement(s) of work as a whole and not to any particular provision of any such document; (e) the words "include", "includes" and "including" (whether or not qualified by the phrase "without limitation" or the like) shall not in any way limit the generality of the provision preceding such word, preclude any other applicable item encompassed by the provision preceding such word, or be deemed or construed to do so; (f) unless the context clearly requires otherwise, the word "or" shall have both the inclusive and alternative meaning represented by the phrase "and/or"; (g) each reference to any financial or reporting control or governing document or policy of the Company shall include those of its ultimate parent, SGRP, or any Nasdaq or SEC rule or other Applicable Law, whether generically or specifically, shall mean the same as then in effect; (h) each provision of this Agreement shall be interpreted fairly as to each Party irrespective of the primary drafter of such provision; (i) the provisions of this Agreement are for the exclusive benefit of the Parties hereto, and except as otherwise expressly provided herein with respect to a Party's Affiliates and their Representatives (e.g., confidentiality, indemnification or the like), no other person (including any creditor), shall have any right or claim against any Party by reason of any of those provisions or be entitled to enforce any of those provisions against any Party; (j) and (k) all references in this Agreement to dollars ($) shall mean U.S. Dollars unless otherwise specified.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00325-of-00352.parquet"}]]